enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Empagliflozin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin

   Empagliflozin, sold under the brand name Jardiance (/ ˈ dʒ ɑːr d i ə n s / JAR-dee-əns), among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. [12] [2] [14] It is taken by mouth. [2]

3. Empagliflozin/metformin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin/metformin

   In the United States it is also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. [ 5 ] In June 2023, the US Food and Drug Administration (FDA) expanded the indication, as an addition to diet and exercise, to improve blood sugar control in children 10 years and ...

4. Zoledronic acid - Wikipedia

   en.wikipedia.org/wiki/Zoledronic_acid

   Zoledronic acid, also known as zoledronate and sold under the brand name Zometa among others, [7] by Novartis among others, is a medication used to treat a number of bone diseases. [3] These include osteoporosis , high blood calcium due to cancer , bone breakdown due to cancer, Paget's disease of bone [ 3 ] and Duchenne muscular dystrophy (DMD).

5. Are Ozempic side effects more common in females? - AOL

   www.aol.com/ozempic-side-effects-more-common...

   Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. ... This drug class also includes other medications for type 2 diabetes (e.g ...

6. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

   www.aol.com/diabetes-drugs-really-safe-reliable...

   The most common side effects of GLP-1 medications are gastrointestinal issues, including: Constipation. ... These severe adverse effects of weight loss diabetes drugs are uncommon, but they’re ...

7. Why Doctors Are Calling This Common Medication a ... - AOL

   www.aol.com/why-doctors-calling-common...

   New research published in the journal Diabetes Care analyzed health records from nearly 76,000 adults who took metformin for type 2 diabetes and compared them to more than 13,000 adults who took ...